AAAAAA
Results:
1-7
|
Results: 7
Authors:
BROCKS DR
UPWARD J
DAVY M
HOWLAND K
COMPTON C
MCHUGH C
DENNIS MJ
Citation: Dr. Brocks et al., EVENING DOSING IS ASSOCIATED WITH HIGHER PLASMA-CONCENTRATIONS OF PRANLUKAST, A LEUKOTRIENE RECEPTOR ANTAGONIST, IN HEALTHY MALE-VOLUNTEERS, British journal of clinical pharmacology, 44(3), 1997, pp. 289-291
Authors:
BROCKS DR
UPWARD J
HUST R
KOESTER FE
COLLIE H
QIAN Y
DENNIS MJ
Citation: Dr. Brocks et al., THE PHARMACOKINETICS OF PRANLUKAST IN HEALTHY-YOUNG AND ELDERLY SUBJECTS, International journal of clinical pharmacology and therapeutics, 34(9), 1996, pp. 375-379
Authors:
RUSSO R
PATTERSON N
ROBERSON D
STEVENSON N
UPWARD J
Citation: R. Russo et al., EMOTIONAL VALUE OF INFORMATION AND ITS RELEVANCE IN THE INTERPRETATION OF HOMOPHONES IN ANXIETY, Cognition and emotion, 10(2), 1996, pp. 213-220
Authors:
RUSSO R
PATTERSON N
ROBERSON D
STEVENSON N
UPWARD J
Citation: R. Russo et al., EMOTIONAL VALUE OF INFORMATION AND ITS RELEVANCE IN THE INTERPRETATION OF HOMOPHONES IN ANXIETY, International journal of psychology, 31(3-4), 1996, pp. 18419-18419
Authors:
CRAFT AW
PRICE L
EDEN OB
SHAW P
CAMPBELL R
PIERCE DM
MURDOCH R
UPWARD J
Citation: Aw. Craft et al., GRANISETRON AS ANTIEMETIC THERAPY IN CHILDREN WITH CANCER, Medical and pediatric oncology, 25(1), 1995, pp. 28-32
Authors:
ALLEN A
CROME P
DAVIE CC
DAVY M
JONES RW
PIERCE DM
UPWARD J
WIJAYAWARDHANA P
Citation: A. Allen et al., THE PHARMACOKINETICS OF GRANISETRON, A 5-HT3 ANTAGONIST IN HEALTHY-YOUNG AND ELDERLY VOLUNTEERS, European Journal of Clinical Pharmacology, 48(6), 1995, pp. 519-520
Authors:
ALLEN A
ASGILL CC
PIERCE DM
UPWARD J
ZUSSMAN BD
Citation: A. Allen et al., PHARMACOKINETICS AND TOLERABILITY OF ASCENDING INTRAVENOUS DOSES OF GRANISETRON, A NOVEL 5-HT3 ANTAGONIST, IN HEALTHY-HUMAN SUBJECTS, European Journal of Clinical Pharmacology, 46(2), 1994, pp. 159-162
Risultati:
1-7
|